COM902

· Compugen Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COM902, covering 2025-05-22 to 2025-05-22. Get the full timeline:

Most recent: Clinical Trial Update: COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies [Phase 1]